{
    "2019-08-29": [
        [
            {
                "time": "",
                "original_text": "四大民营药店中报毛利率承压，处方药销售增收不增利 盈利能力下降",
                "features": {
                    "keywords": [
                        "民营药店",
                        "毛利率",
                        "处方药",
                        "增收不增利",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "17家医药公司上半年净利翻倍 创新药等四大细分领域表现突出",
                "features": {
                    "keywords": [
                        "医药公司",
                        "净利翻倍",
                        "创新药",
                        "细分领域",
                        "表现突出"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}